DIA Elects Cancer Genetics, Inc.’s John A. (Jay) Roberts as Chairman of DIA Board of Directors
Aug 03, 2017 11:30 am UTC| Business
DIA is a professional community and knowledge exchange network for global health care product developmentMr. Roberts, who is also the Chief Operating Officer and EVP of Finance at Cancer Genetics, Inc. (Nasdaq:CGIX) will...
Adaptimmune Reports Second Quarter 2017 Financial Results
Aug 03, 2017 11:30 am UTC| Business
– A registered direct offering in April combined with a public offering in March raised net proceeds of $103.2 million; operations funded through to late 2019 – – Enrolling 9 clinical studies with NY-ESO as well...
Repligen Reports Second Quarter 2017 Financial Results
Aug 03, 2017 11:30 am UTC| Business
Record quarterly revenue of $32.5 millionFirst half 2017 revenue growth of 16% or 18% at constant currencyEnters agreement to acquire Spectrum, Inc., which closed August 1Prices follow-on offering which netted proceeds of...
Aug 03, 2017 11:30 am UTC| Business
BELGRADE, Mont., Aug. 03, 2017 -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, is proud to announce its sponsorship of the 2018...
Minerva Neurosciences Reports Second Quarter 2017 Financial Results and Business Updates
Aug 03, 2017 11:30 am UTC| Business
FDA feedback on clinical trial design and completion of bridging study with new formulation enable initiation of Phase 3 trial with MIN-101 to treat negative symptoms of schizophrenia in second half of 2017 Amended...
MGP Ingredients Declares $0.04 Quarterly Dividend
Aug 03, 2017 11:25 am UTC| Business
ATCHISON, Kan., Aug. 03, 2017 -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today announced that its board of directors has declared a...
Aug 03, 2017 11:17 am UTC| Business
Delivered quarterly sales volumes of 408 MBoe/d, up 7 percent from the first quarter of 2017 and in the upper half of the Company’s increased guidance range when adjusted for the timing impact of the Marcellus sale...